Specialty Business Services
Compare Stocks
4 / 10Stock Comparison
SMX vs IDAI vs COHU vs ACXP
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Semiconductors
Biotechnology
SMX vs IDAI vs COHU vs ACXP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Business Services | Software - Application | Semiconductors | Biotechnology |
| Market Cap | $497.00 | $3M | $2.23B | $5M |
| Revenue (TTM) | $0.00 | $4M | $481M | $0.00 |
| Net Income (TTM) | $-4M | $-12M | $-56M | $-7.97B |
| Gross Margin | — | 60.0% | 25.7% | — |
| Operating Margin | — | -183.3% | -10.6% | — |
| Forward P/E | — | — | 89.2x | — |
| Total Debt | $6M | $4M | $359M | $0.00 |
| Cash & Equiv. | $2M | $3M | $227M | $7.56B |
SMX vs IDAI vs COHU vs ACXP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| SMX (Security Matte… (SMX) | 100 | 0.0 | -100.0% |
| T Stamp Inc. (IDAI) | 100 | 0.8 | -99.2% |
| Cohu, Inc. (COHU) | 100 | 124.7 | +24.7% |
| Acurx Pharmaceutica… (ACXP) | 100 | 2.5 | -97.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SMX vs IDAI vs COHU vs ACXP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SMX is the #2 pick in this set and the best alternative if efficiency is your priority.
- -2.8% ROA vs ACXP's -413.5%
IDAI is the clearest fit if your priority is income & stability.
- beta 1.99
- Beta 1.99 vs SMX's 4.47
COHU carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 12.7%, EPS growth -6.7%, 3Y rev CAGR -17.7%
- 330.2% 10Y total return vs SMX's 12.0%
- Lower volatility, beta 2.13, Low D/E 45.8%, current ratio 6.88x
- Beta 2.13, current ratio 6.88x
ACXP lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% revenue growth vs IDAI's -32.4% | |
| Quality / Margins | -11.5% margin vs IDAI's -316.4% | |
| Stability / Safety | Beta 1.99 vs SMX's 4.47 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +199.7% vs SMX's -100.0% | |
| Efficiency (ROA) | -2.8% ROA vs ACXP's -413.5% |
SMX vs IDAI vs COHU vs ACXP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
SMX vs IDAI vs COHU vs ACXP — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
COHU leads in 2 of 6 categories
SMX leads 1 • IDAI leads 0 • ACXP leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
COHU leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHU and ACXP operate at a comparable scale, with $481M and $0 in trailing revenue. Profitability is closely matched — net margins range from -11.5% (COHU) to -3.2% (IDAI). On growth, IDAI holds the edge at +70.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $4M | $481M | $0 |
| EBITDAEarnings before interest/tax | -$4M | -$6M | -$11M | $35,910 |
| Net IncomeAfter-tax profit | -$4M | -$12M | -$56M | -$8.0B |
| Free Cash FlowCash after capex | -$1M | -$8M | $32M | $4.6B |
| Gross MarginGross profit ÷ Revenue | — | +60.0% | +25.7% | — |
| Operating MarginEBIT ÷ Revenue | — | -183.3% | -10.6% | — |
| Net MarginNet income ÷ Revenue | — | -3.2% | -11.5% | — |
| FCF MarginFCF ÷ Revenue | — | -2.2% | +6.6% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +70.7% | +29.3% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -647.6% | +32.1% | +60.6% | +98.2% |
Valuation Metrics
Evenly matched — SMX and IDAI and COHU each lead in 1 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $497 | $3M | $2.2B | $5M |
| Enterprise ValueMkt cap + debt − cash | $4M | $4M | $2.4B | -$7.6B |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | -0.22x | -29.86x | -0.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 89.21x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 0.89x | 4.93x | — |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.86x | 2.82x | 0.00x |
| Price / FCFMarket cap ÷ FCF | — | — | 207.83x | — |
Profitability & Efficiency
SMX leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SMX delivers a -3.0% return on equity — every $100 of shareholder capital generates $-3 in annual profit, vs $-6 for ACXP. SMX carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to IDAI's 1.30x. On the Piotroski fundamental quality scale (0–9), COHU scores 4/9 vs IDAI's 1/9, reflecting mixed financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.0% | -189.5% | -6.8% | -6.0% |
| ROA (TTM)Return on assets | -2.8% | -105.4% | -4.9% | -4.1% |
| ROICReturn on invested capital | -40.5% | -2.2% | -5.7% | — |
| ROCEReturn on capital employed | -60.1% | -194.9% | -5.9% | — |
| Piotroski ScoreFundamental quality 0–9 | 3 | 1 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.27x | 1.30x | 0.46x | — |
| Net DebtTotal debt minus cash | $4M | $1M | $132M | -$7.6B |
| Cash & Equiv.Liquid assets | $2M | $3M | $227M | $7.6B |
| Total DebtShort + long-term debt | $6M | $4M | $359M | $0 |
| Interest CoverageEBIT ÷ Interest expense | -1.24x | -22.08x | -168.82x | — |
Total Returns (Dividends Reinvested)
COHU leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in COHU five years ago would be worth $12,218 today (with dividends reinvested), compared to $0 for SMX. Over the past 12 months, COHU leads with a +199.7% total return vs SMX's -100.0%. The 3-year compound annual growth rate (CAGR) favors COHU at 12.1% vs SMX's -99.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.8% | -38.4% | +92.9% | -23.2% |
| 1-Year ReturnPast 12 months | -100.0% | +20.9% | +199.7% | -70.1% |
| 3-Year ReturnCumulative with dividends | -100.0% | -87.5% | +40.7% | -96.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -99.1% | +22.2% | -98.7% |
| 10-Year ReturnCumulative with dividends | +1200.0% | +102.4% | +330.2% | -98.7% |
| CAGR (3Y)Annualised 3-year return | -99.0% | -50.0% | +12.1% | -67.4% |
Risk & Volatility
Evenly matched — IDAI and COHU each lead in 1 of 2 comparable metrics.
Risk & Volatility
IDAI is the less volatile stock with a 1.99 beta — it tends to amplify market swings less than SMX's 4.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COHU currently trades 93.7% from its 52-week high vs SMX's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.47x | 1.99x | 2.13x | 2.42x |
| 52-Week HighHighest price in past year | $20528.69 | $5.28 | $50.68 | $21.00 |
| 52-Week LowLowest price in past year | $1.02 | $1.80 | $15.34 | $1.33 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +47.2% | +93.7% | +10.1% |
| RSI (14)Momentum oscillator 0–100 | 30.1 | 49.1 | 75.5 | 40.9 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 43K | 953K | 3.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — |
| Price TargetConsensus 12-month target | — | — | $49.75 | — |
| # AnalystsCovering analysts | — | — | 14 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% | +0.3% | +100.0% |
COHU leads in 2 of 6 categories (Income & Cash Flow, Total Returns). SMX leads in 1 (Profitability & Efficiency). 2 tied.
SMX vs IDAI vs COHU vs ACXP: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is SMX or IDAI or COHU or ACXP a better buy right now?
For growth investors, Cohu, Inc.
(COHU) is the stronger pick with 12. 7% revenue growth year-over-year, versus -32. 4% for T Stamp Inc. (IDAI). Analysts rate Cohu, Inc. (COHU) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SMX or IDAI or COHU or ACXP?
Over the past 5 years, Cohu, Inc.
(COHU) delivered a total return of +22. 2%, compared to -100. 0% for SMX (Security Matters) Public Limited Company (SMX). Over 10 years, the gap is even starker: SMX returned +1200% versus ACXP's -98. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SMX or IDAI or COHU or ACXP?
By beta (market sensitivity over 5 years), T Stamp Inc.
(IDAI) is the lower-risk stock at 1. 99β versus SMX (Security Matters) Public Limited Company's 4. 47β — meaning SMX is approximately 125% more volatile than IDAI relative to the S&P 500. On balance sheet safety, SMX (Security Matters) Public Limited Company (SMX) carries a lower debt/equity ratio of 27% versus 130% for T Stamp Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — SMX or IDAI or COHU or ACXP?
By revenue growth (latest reported year), Cohu, Inc.
(COHU) is pulling ahead at 12. 7% versus -32. 4% for T Stamp Inc. (IDAI). On earnings-per-share growth, the picture is similar: SMX (Security Matters) Public Limited Company grew EPS 94. 3% year-over-year, compared to -6. 7% for Cohu, Inc.. Over a 3-year CAGR, IDAI leads at -5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SMX or IDAI or COHU or ACXP?
SMX (Security Matters) Public Limited Company (SMX) is the more profitable company, earning 0.
0% net margin versus -344. 1% for T Stamp Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMX leads at 0. 0% versus -303. 9% for IDAI. At the gross margin level — before operating expenses — IDAI leads at 65. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SMX or IDAI or COHU or ACXP?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SMX or IDAI or COHU or ACXP better for a retirement portfolio?
For long-horizon retirement investors, SMX (Security Matters) Public Limited Company (SMX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1200% 10Y return).
Acurx Pharmaceuticals, Inc. (ACXP) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMX: +1200%, ACXP: -98. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SMX and IDAI and COHU and ACXP?
These companies operate in different sectors (SMX (Industrials) and IDAI (Technology) and COHU (Technology) and ACXP (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.